资源描述
HTTP:/WWW.LONGONE.COM.CN S0630522040001 S0630522080001 2023 4 26 HTTP:/WWW.LONGONE.COM.CN 2021 417 9.33%2030 931 6 60%CR580%10000 2021 287 4-5 14 XVBYzQrMpMrQsMoNtOtMpOaQbP6MsQqQnPoNjMpPmQkPpNoR9PmMvMwMmMsNNZoOpO HTTP:/WWW.LONGONE.COM.CN HTTP:/WWW.LONGONE.COM.CN CONTENTS HTTP:/WWW.LONGONE.COM.CN 01 HTTP:/WWW.LONGONE.COM.CN 55%90%7%3%60%15%4%21%HTTP:/WWW.LONGONE.COM.CN 100 20 主要用途 1 2 3 4 5 6 G X G G G HBsAg(TAT)VIII HTTP:/WWW.LONGONE.COM.CN 1941 Cohn 1940-1990 1990-HTTP:/WWW.LONGONE.COM.CN RESEARCH AND MARKETS 2021 417 9.33%2030 931 CSL Octopharma Grifols 80-85%HTTP:/WWW.LONGONE.COM.CN PPTA 6 60%2021 1041 2020 2021 42801 RESEARCH AND MARKETS HTTP:/WWW.LONGONE.COM.CN 4-5 2021 287 28%2021 9390 22%2021 58 CSL 20%2021 PPTA CSL Grifols Octapharma 2021300+340+180+58 41 25 HTTP:/WWW.LONGONE.COM.CN 2021 287 1041 2021 9390 42801/32.7 41.1 2/14 2/72 580ml 690-880ml-FDA HTTP:/WWW.LONGONE.COM.CN 02 HTTP:/WWW.LONGONE.COM.CN/14 24 600 18-55 60 50KG 45KG HCV HIV-1 HIV-2/HTTP:/WWW.LONGONE.COM.CN/6 5 HTTP:/WWW.LONGONE.COM.CN/60 HTTP:/WWW.LONGONE.COM.CN/1985 2002 2007 11 2001 30 HTTP:/WWW.LONGONE.COM.CN 60 1966 1980 1984 20 90 2007 2008 2006 2004 2001 1998 1996 GMP GMP 36 90 6 HTTP:/WWW.LONGONE.COM.CN 2002-2010 2002-2010 2500-5000 HTTP:/WWW.LONGONE.COM.CN 2011-2021 2012 2017 2020 HTTP:/WWW.LONGONE.COM.CN 2011-2021 57 2011 3858 2015 5946 CAGR 11.4%54 2016 7100 2020 8300 2020 2016-2019 CAGR 9.0%2011 1462012 1512013 1652014 1782015 2032016 2232017 2312018 2532019 2572020 2712021 287 HTTP:/WWW.LONGONE.COM.CN 2021-2023 19 2 2022-2025 6 7 2021-2023 4 3 30 HTTP:/WWW.LONGONE.COM.CN 2002-2010 2011 26.4 2019 35.8 2020 2021 2019 4 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 3858 4285 4979 5207 5946 7100 8081 8600 9200 8300 9390 146 151 165 178 203 223 231 253 257 271 287 26.4 28.4 30.2 29.3 29.3 31.8 35.0 34.0 35.8 30.6 32.7 HTTP:/WWW.LONGONE.COM.CN 2021 75%2001 28 6 4 2 2 2 2 1 1 HTTP:/WWW.LONGONE.COM.CN 2013 4033 2020 9907 2013-2020 13.7%2021 HTTP:/WWW.LONGONE.COM.CN 2017-2021 13.7%2017-2021 18.3%HTTP:/WWW.LONGONE.COM.CN 2022 5 5 2022 50ml:10g 401 550 350 2.5g 574 650 538 0.3g 166 260 103 200IU 395 411 370 0.5g 858 940 699 HTTP:/WWW.LONGONE.COM.CN 03 HTTP:/WWW.LONGONE.COM.CN 20 40 Cohn VIII 10 HTTP:/WWW.LONGONE.COM.CN 100 20+3 14 CSL CSL pH4 pH4 VIIIC1 III XIII IX IX X VIII Alpha-1 HTTP:/WWW.LONGONE.COM.CN 62%28%11%2021 pH4 pH4 pH4 HTTP:/WWW.LONGONE.COM.CN 50 60 1 2 3 30g/L HTTP:/WWW.LONGONE.COM.CN 2020 6000 10g/2015-2020 CAGR 12.4%2021 275 2015-2021 CAGR 15.6%HTTP:/WWW.LONGONE.COM.CN 60%2022 63%37%10000 2500 2020 6000 2022 HTTP:/WWW.LONGONE.COM.CN PPTA 6000 10g/411g/PPTA 220924kg 665g/600000 kg 220924 14.59 3.32 g/411.2 g/665.4 600g/8754 10g/35000 HTTP:/WWW.LONGONE.COM.CN 2020 2030 Allied Market Research HTTP:/WWW.LONGONE.COM.CN X G/TAT/(HBsAg)/(HBV)HBV HTTP:/WWW.LONGONE.COM.CN V2.0)COVID-19 2022 HTTP:/WWW.LONGONE.COM.CN NCBI X XLA ITP(CVID)(SCID)MMN-IgA CIDP IgG SAD IgM HIGM-DiGeorge()IgE(HIES)Ig B(CLL)(MM)-B Ig 1.2.HTTP:/WWW.LONGONE.COM.CN 30 ICU 150 500 mg/(kg)2 4 1 200 300 mg/(kg)2 d 500 mg/(kg)3 6 d(CMV)200 500 mg/(kg)2 3 1 150 500 mg/(kg)2 3 1 300 400 mg/(kg)3 d 200 400 mg/(kg)3 5 d400 mg/(kg)5 d1 000 mg/(kg)2 d2 000 g/(kg)1 dHUS 400 mg/(kg)3 5 d 1 000 mg/(kg)4 d 400 1 000 mg/(kg)2 5 d 400 mg/(kg)1 3 1 200 500 mg/(kg)/2 000 mg/(kg)/500 mg/(kg)1 GBS 250 400 mg/(kg)7 14 d2 000 mg/(kg)1 d1 000 mg/(kg)2 dMMN 1 000 mg/(kg)2 dAD 1 200 mg/(kg)3 d 1 6 KD 2 000 mg/(kg)1 d 400 mg/(kg)3 d(MG)500 mg/(kg)6 d(MS)400 mg/(kg)5 d(CTD)1 000 mg/(kg)1 d 2 4 1(SLE)400 mg/(kg)3 5 d 200 mg/(kg)1 d CIDP ITP 4 6 1 HTTP:/WWW.LONGONE.COM.CN FDA 5%FDA FDA Asceniv ANTHRASILBivigam BabyBIGCarimune NF,Nanofiltered CytoGamFlebogamma DIF 5%&10%HepaGam BFlebogamma DIF 10%KEDRABGammagard Liquid Nabi-HBGammagard S/D RhophylacGammaplex 5%&10%Vaccinia Immune Globulin Intravenous(Human)Gamunex-C,Gammaked VARIZIGOCTAGAM WinRho SDF LiquidPANZYGA Privigen Atgam AnascorpCutaquig ANAVIPCUVITRU Black Widow Spider Antivenin(Equine)Gammagard Liquid Botulism Antitoxin Bivalent(Equine)Types A and BGamunex-C,GammakedHizentraHYQVIA Coral Snake AntivenomXembify CroFab DigiFabGamaSTAN S/D,Immune Globulin(Human)ThymoglobulinBAT(Botulism Antitoxin Heptavalent(A,B,C,D,E,F,G)-(Equine)HTTP:/WWW.LONGONE.COM.CN 2020 1255 2.5g/2015-2020 CAGR 7.7%2021 85.5 2015-2021 CAGR 8.0%HTTP:/WWW.LONGONE.COM.CN PPTA 1250 2.5g/21.4g/PPTA 113024kg 340.4g/1/2-2/3 170-226g/8-10 kg 31250 kg 113024 14.59 3.32 g/340.4 g/170-226 g/21.4 80-100 800 HTTP:/WWW.LONGONE.COM.CN/IX/A VIII IX B IX/,HTTP:/WWW.LONGONE.COM.CN 2021 48 2015-2021 CAGR 24%2021 HTTP:/WWW.LONGONE.COM.CN 2/3 2020 200 200IU/HTTP:/WWW.LONGONE.COM.CN PPTA 200 200IU/1/3 0.8 IU/PPTA 84%16%4.7IU/6 30 12 180 1000 IU 400000 1000 IU 256468 1000 IU 1306160 1000 IU 1200000 1000 IU 1562628 14.59 3.32 IU/0.82 IU/4.71 HTTP:/WWW.LONGONE.COM.CN 04 HTTP:/WWW.LONGONE.COM.CN Wind 2023 4 26A 202120212021600161.SH 440 41.1 58 1809 12002252.SZ 415 42.9 41 1280 12002007.SZ 421 44.4 25 1000 11000403.SZ 171 19.7 27 900 10300294.SZ 192 26.5 14 420 9002880.SZ 69 9.1 8 400 9300318.SZ 44 7.1 12 253 7 HTTP:/WWW.LONGONE.COM.CN 2023 600161.SH 002252.SZ 002007.SZ 300294.SZ 000403.SZ()002880.SZ 300318.SZ,HTTP:/WWW.LONGONE.COM.CN 2017-2018 2021 HTTP:/WWW.LONGONE.COM.CN Wind 6 4 2 1 HTTP:/WWW.LONGONE.COM.CN 2017 2018 2019 2020 2021 47 49 52 55 58 39 41 41 41 41 24 25 25 25 25 12 12 12 13 14 11 11 11 26 27 7 7 8 8 8 11 11 11 11 12 HTTP:/WWW.LONGONE.COM.CN 500 2017 2018 2019 2020 2021 1400 1568 1706 1714 1809 1000 1180 1230 1200 1280 1100 1000 1000 1000 1000 320 350 372 378 420 349 400 400 900 340 382 400 180 235 282 157 253 HTTP:/WWW.LONGONE.COM.CN 50 40 20 30 2017 2018 2019 2020 2021 29.8 32.0 32.8 31.2 31.2 25.6 28.8 30.0 29.3 31.2 45.8 40.0 40.0 40.0 40.0 26.7 29.2 31.0 29.1 30.0 31.7 36.4 36.4 33.3 48.6 47.8 50.0 16.4 21.4 25.6 14.3 21.1 HTTP:/WWW.LONGONE.COM.CN 10 pH4 pH4 12 12 11 10 10 9 9 7 HTTP:/WWW.LONGONE.COM.CN 2021 40 2018 2021 20212017-2021CAGR 41.0 28.3%33.3 14.8%26.0 5.7%12.1 13.4%19.7 30.2%8.9 9.7%3.6 18.1%HTTP:/WWW.LONGONE.COM.CN/2017 2018 2019 2020 2021 108 187 192 200 227 192 153 210 230 260 189 241 264 259 260 229 250 266 236 288 196 212 227 218 181 234 222 103 136 109 218 140 HTTP:/WWW.LONGONE.COM.CN 2021 HTTP:/WWW.LONGONE.COM.CN 600161 6 102 70(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)(pH4)2018 2019 2020 2021 2022 29.29 32.74 34.34 40.98 42.44 47.14%49.76%49.57%47.45%49.00%HTTP:/WWW.LONGONE.COM.CN 002007 7 2018-2021(pH4)(pH4)2018 2019 2020 2021 2022 25 25 25 25 28 24.1 26.4 25.9 26.0 26.8 58.8%57.1%57.1%55.3%52.3%1000-1100 7 HTTP:/WWW.LONGONE.COM.CN 300294 2022 PCC 2022 2021 30 2018 2019 2020 2021 2022 350 372 378 420 439 12 12 13 14 14 7 7 8 8 9 HTTP:/WWW.LONGONE.COM.CN HTTP:/WWW.LONGONE.COM.CN 6 20%6-20%20%6 20%6 10%6-10%10%6 10%6 15%6 5%15%6-5%5%6 5%15%6 15%HTTP:/WWW.LONGONE.COM.CN c 1928 87 D 15F Http:/Http:/8621 20333619 8610 59707105 8621 50585608 8610 59707100 200215 100089 HTTP:/WWW.LONGONE.COM.CN P R A G M A T I C I N N O V A T I V E D I S C I P L I N E D C O L L A B O R A T I V E 前沿报告库是中国新经济产业咨询报告共享平台。行业范围涵盖新一代信息技术、5G、物联网、新能源、新材料、新消费、大健康、大数据、智能制造等新兴领域。为企事业单位、科研院所、投融资机构等提供研究和决策参考。扫一扫免费获取海量报告
展开阅读全文